(Applicant's Description) This application requests renewal of the Cancer Center Support Grant (CCSG) of the NCI-designated Comprehensive Cancer Center (CCC) of Metropolitan Detroit at Wayne State University. The Programs of the CCC reflect the cancer needs of the greater Metropolitan Detroit area. This is an industrialized, urban and ethnically diverse community with a disproportionate number of medically disadvantaged, low socio-economic citizens. This CCC has a long-standing and extensive community network dedicated to the prevention, earlier detection and treatment of cancer, particularly of urban minority, African American and Arab American populations which experience disproportionate mortality from breast, prostate and aerodigestive cancers. Our grant requests support for six research programs, ten core facilities, and related administrative activity. The CCC's established cancer research programs are Breast Cancer; Developmental Therapeutics; Molecular Biology and Genetics; Population Studies and Prevention; Prostate Cancer; and Proteases. CCSG support is also requested for Cores in Biostatistics, Clinical Trials, Cell Resources, Genetics/Genomics, Human Tissues and Pathology, Confocal Microscopy, Flow Cytometry, Nutrition, Community-Based Research Management and Pharmacology. Our Programs are organized to integrate basic, translational, and clinical research with population research-based, cancer control activities. An asset of our Center is our Metropolitan Detroit Cancer Surveillance System, a member of the NCI-sponsored SEER registry system. The programs represent focused and targeted research efforts aimed at addressing the special and unique characteristics and needs of cancer patients in our community and region. During the grant period, particular emphasis is to be placed on research issues related to the early events in breast cancer, on development of prevention research in breast, prostate and lung cancer, on the translation of that research into the community, and on the development of novel therapeutic approaches to these high-morbidity and mortality cancers. In addition, strong basic research efforts in molecular genetics and in understanding mechanisms of invasion and metastasis will be foundations for both clinical and community-based research. The CCC will continue to foster multidisciplinary interactions and collaborations, and to utilize CCSG developmental funds and other support to recruit new investigators and to develop translational research programs that have a high potential for peer- reviewed funding.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA022453-22S1
Application #
6503249
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ptak, Krzysztof
Project Start
1988-04-01
Project End
2002-11-30
Budget Start
2001-09-27
Budget End
2001-11-30
Support Year
22
Fiscal Year
2001
Total Cost
$192,972
Indirect Cost
Name
Wayne State University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Kraniak, Janice M; Chalasani, Anita; Wallace, Margaret R et al. (2018) Development of 3D culture models of plexiform neurofibroma and initial application for phenotypic characterization and drug screening. Exp Neurol 299:289-298
An, Myunggi; Yu, Chunsong; Xi, Jingchao et al. (2018) Induction of necrotic cell death and activation of STING in the tumor microenvironment via cationic silica nanoparticles leading to enhanced antitumor immunity. Nanoscale 10:9311-9319
Neslund-Dudas, Christine M; McBride, Russell B; Kandegedara, Ashoka et al. (2018) Association between cadmium and androgen receptor protein expression differs in prostate tumors of African American and European American men. J Trace Elem Med Biol 48:233-238
Wu, Jheng-Yu; Xiang, Shengyan; Zhang, Mu et al. (2018) Histone deacetylase 6 (HDAC6) deacetylates extracellular signal-regulated kinase 1 (ERK1) and thereby stimulates ERK1 activity. J Biol Chem 293:1976-1993
Negmeldin, Ahmed T; Knoff, Joseph R; Pflum, Mary Kay H (2018) The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity. Eur J Med Chem 143:1790-1806
Tamura, Koji; Yu, Jun; Hata, Tatsuo et al. (2018) Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. Proc Natl Acad Sci U S A 115:4767-4772
Matherly, Larry H; Hou, Zhanjun; Gangjee, Aleem (2018) The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer. Cancer Chemother Pharmacol 81:1-15
Pollack, Murray M; Holubkov, Richard; Reeder, Ron et al. (2018) PICU Length of Stay: Factors Associated With Bed Utilization and Development of a Benchmarking Model. Pediatr Crit Care Med 19:196-203
Bao, Xun; Wu, Jianmei; Sanai, Nader et al. (2018) A liquid chromatography with tandem mass spectrometry method for quantitating total and unbound ceritinib in patient plasma and brain tumor. J Pharm Anal 8:20-26
Heath, Elisabeth I; Lynce, Filipa; Xiu, Joanne et al. (2018) Racial Disparities in the Molecular Landscape of Cancer. Anticancer Res 38:2235-2240

Showing the most recent 10 out of 826 publications